Ikena Oncology Stock Price Prediction
| IKNA Stock | USD 1.73 0.03 1.76% |
Oversold Vs Overbought
60
Oversold | Overbought |
EPS Estimate Next Quarter (0.23) | EPS Estimate Current Year (0.92) | EPS Estimate Next Year (0.84) | Wall Street Target Price 3 | EPS Estimate Current Quarter (0.27) |
Using Ikena Oncology hype-based prediction, you can estimate the value of Ikena Oncology from the perspective of Ikena Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ikena Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Ikena because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ikena Oncology after-hype prediction price | USD 1.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ikena |
Ikena Oncology After-Hype Price Prediction Density Analysis
As far as predicting the price of Ikena Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ikena Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ikena Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ikena Oncology Estimiated After-Hype Price Volatility
In the context of predicting Ikena Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ikena Oncology's historical news coverage. Ikena Oncology's after-hype downside and upside margins for the prediction period are 0.29 and 3.17, respectively. We have considered Ikena Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ikena Oncology is somewhat reliable at this time. Analysis and calculation of next after-hype price of Ikena Oncology is based on 3 months time horizon.
Ikena Oncology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ikena Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ikena Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ikena Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 1.44 | 0.00 | 0.02 | 3 Events / Month | 5 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.73 | 1.73 | 0.00 |
|
Ikena Oncology Hype Timeline
Ikena Oncology is currently traded for 1.73. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Ikena is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.09%. %. The volatility of related hype on Ikena Oncology is about 717.41%, with the expected price after the next announcement by competition of 1.71. About 64.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.62. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ikena Oncology recorded a loss per share of 1.23. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 3 days. Check out Ikena Oncology Basic Forecasting Models to cross-verify your projections.Ikena Oncology Related Hype Analysis
Having access to credible news sources related to Ikena Oncology's direct competition is more important than ever and may enhance your ability to predict Ikena Oncology's future price movements. Getting to know how Ikena Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ikena Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LYRA | Lyra Therapeutics | 0.01 | 5 per month | 0.00 | (0.13) | 8.00 | (10.00) | 41.07 | |
| HOOK | Hookipa Pharma | (0.05) | 6 per month | 0.00 | (0.33) | 4.05 | (7.24) | 15.72 | |
| CINGW | Cingulate Warrants | 0.01 | 1 per month | 0.00 | (0.03) | 34.83 | (25.20) | 92.13 | |
| SABS | SAB Biotherapeutics | (0.39) | 8 per month | 6.39 | 0.05 | 17.06 | (11.25) | 45.73 | |
| CVKD | Cadrenal Therapeutics, Common | 1.25 | 10 per month | 6.10 | 0.15 | 17.85 | (7.47) | 47.47 | |
| MNPR | Monopar Therapeutics | (2.62) | 9 per month | 7.94 | 0.13 | 15.93 | (9.50) | 653.56 | |
| SPRO | Spero Therapeutics | 0.02 | 10 per month | 0.00 | (0.12) | 3.79 | (4.58) | 14.92 | |
| CHRS | Coherus BioSciences | 0.01 | 9 per month | 4.72 | (0.02) | 7.62 | (6.94) | 26.43 | |
| IKNA | Ikena Oncology | (0.05) | 3 per month | 1.38 | (0.06) | 1.81 | (1.74) | 13.50 |
Ikena Oncology Additional Predictive Modules
Most predictive techniques to examine Ikena price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ikena using various technical indicators. When you analyze Ikena charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ikena Oncology Predictive Indicators
The successful prediction of Ikena Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ikena Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ikena Oncology based on analysis of Ikena Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ikena Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ikena Oncology's related companies.
Story Coverage note for Ikena Oncology
The number of cover stories for Ikena Oncology depends on current market conditions and Ikena Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ikena Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ikena Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ikena Oncology Short Properties
Ikena Oncology's future price predictability will typically decrease when Ikena Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ikena Oncology often depends not only on the future outlook of the potential Ikena Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ikena Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.7 M | |
| Cash And Short Term Investments | 175.5 M |
Complementary Tools for Ikena Stock analysis
When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |